Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
Annual report for 2021
March 2022
Important tips
(I) the board of directors, the board of supervisors and the directors, supervisors and senior managers of the company guarantee that the contents of this annual report are true, accurate and complete, and there are no false records, misleading statements or major omissions, and bear individual and joint legal liabilities.
(II) all directors of the company attended the 19th meeting of the 8th board of directors, among which Mr. Huang Xianrong, an independent non-executive director, attended the meeting by means of communication.
(III) the financial reports of the group and the company for the year ended December 31, 2021 were prepared in accordance with the Chinese accounting standards for business enterprises, audited by Lixin Certified Public Accountants (special general partnership) and issued a standard unqualified audit report.
(IV) Mr. Li Chuyuan, chairman of the company, Ms. Liu Fei, deputy chief financial officer and Ms. Wu Chuling, deputy director of the finance department, declare that they guarantee the authenticity, accuracy and completeness of the financial report in this annual report.
(V) the profit distribution plan or the plan of converting accumulation fund into share capital in the reporting period reviewed by the board of directors
The audit of Lixin Certified Public Accountants (special general partnership) confirmed that in 2021, the group realized the consolidated net profit attributable to the shareholders of the company of RMB 371987768046. Based on the company’s net profit of RMB 188410981135 in 2021, 10% statutory surplus reserve of RMB 18841098114 was withdrawn, plus the undistributed profit carried forward at the beginning of last year of RMB 67785 Cecep Wind-Power Corporation(601016) 2, After deducting the cash dividend of RMB 87467553056 in 2020, the profit available for distribution at the end of the period is RMB 759958340127.
According to the actual situation of the company, based on the total share capital of 1625790949 shares at the end of 2021, it is proposed to distribute cash dividends of RMB 6.87 (including tax) for every 10 shares, with a total of RMB 111691838196 distributed. The remaining undistributed shares will be transferred to the next distribution. No capital reserve will be converted into share capital in this year.
The profit distribution plan is proposed to be submitted to the 2021 annual general meeting of the company for deliberation and approval.
(VI) the future plans, development strategies and other forward-looking descriptions involved in this annual report do not constitute the company’s substantive commitment to investors. Please pay attention to investment risks.
(VII) the company has no non operational occupation of funds by the controlling shareholders and their related parties.
(VIII) there is no violation of the company’s decision-making procedures.
(IX) more than half of the directors of the company cannot guarantee the authenticity, accuracy and completeness of the annual report disclosed by the company.
(x) tips on major risks
During the reporting period, there were no particularly significant risks that had a material impact on the production and operation of the group. This report has described in detail the various risks and countermeasures that the group may face in the process of production and operation. Please refer to the section “(III) possible risks” of “VI. discussion and analysis of the company on the future development” in Section III “management discussion and analysis” of this report.
（11） This annual report is compiled in Chinese and English respectively. In case of any ambiguity in interpretation between the two versions, the Chinese version shall prevail.
catalogue
Section 1 interpretation Section 2 company profile and main financial indicators 5 Section III Management Discussion and Analysis Section IV corporate governance Section V environmental and social responsibility 103 section VI important matters Section VII changes in ordinary shares and shareholders 139 Section VIII preferred shares 147 section IX relevant information of corporate bonds 148 section x financial reporting one hundred and forty-nine
1、 Financial statements containing the signatures and seals of the legal representative and the person in charge of accounting of the company;
2、 The contents of the audit report for future reference signed by Lixin Certified Public Accountants (special general partnership) and the original financial and accounting report prepared in accordance with the Chinese accounting standards for business enterprises;
3、 The originals of the company’s documents and announcements publicly disclosed in Shanghai Securities News, securities times, China Securities News and securities daily during the reporting period;
4、 Storage place of documents: the secretary room of the board of directors of the company.
Section I interpretation
In this annual report, unless the context otherwise requires, the following words have the following meanings:
Company / the company / Guangzhou Pharmaceutical Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) refers to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332)
China means the people’s Republic of China
The reporting period / year / year refers to the period from January 1, 2021 to December 31, 2021
The group refers to the company and its subsidiaries
Board of directors means the board of directors of the company
Director means a director of the company
Board of supervisors refers to the board of supervisors of the company
Supervisor refers to the supervisor of the company
CSRC refers to the China Securities Regulatory Commission
Shanghai stock exchange refers to Shanghai Stock Exchange
HKEx means the stock exchange of Hong Kong Limited
Guangzhou SASAC refers to the state owned assets supervision and Administration Commission of Guangzhou Municipal People’s government
Company Law refers to the company law of the people’s Republic of China
Securities Law refers to the securities law of the people’s Republic of China
Articles of association means the articles of association of the company
The HKEx Listing Rules refer to the HKEx securities listing rules
The Listing Rules of Shanghai Stock Exchange refer to the stock listing rules of Shanghai Stock Exchange
Securities Ordinance means the securities and Futures Ordinance (Chapter 571 of the laws of Hong Kong)
The standard code refers to the standard code for securities transactions by directors of listed issuers in Appendix 10 to the Securities Listing Rules of the Hong Kong stock exchange
Guangzhou Pharmaceutical Group refers to Guangzhou Pharmaceutical Group Co., Ltd
Guangzhou Pharmaceutical refers to Guangzhou Pharmaceutical Co., Ltd
Guangzhou Xingqun Pharmaceutical Co., Ltd
Zhongyi pharmaceutical refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Zhongyi Pharmaceutical Co., Ltd
Chen Liji pharmaceutical factory refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Chen Liji Pharmaceutical Factory Co., Ltd
Qixing pharmaceutical refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Qixing Pharmaceutical Co., Ltd
PanGaoShou pharmaceutical refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) PanGaoShou Pharmaceutical Co., Ltd
Jingxiutang pharmaceutical means Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) jingxiutang Pharmaceutical Co., Ltd
Wanglaoji pharmaceutical refers to Guangzhou Wanglaoji Pharmaceutical Co., Ltd
Guangzhou Hanfang means Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hanfang Modern Pharmaceutical Co., Ltd
Guangxi Yingkang refers to Guangxi Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Yingkang Pharmaceutical Co., Ltd
Wanglaojida health Co., Ltd. refers to Guangzhou wanglaojida Health Industry Co., Ltd
Wanglaoji catering company refers to Guangzhou Wanglaoji Catering Management Development Co., Ltd
Pharmaceutical company refers to Guangzhou Pharmaceutical Co., Ltd
Caizhilin pharmaceutical refers to Guangzhou Caizhilin Pharmaceutical Co., Ltd
Pharmaceutical import and Export Corporation refers to Guangzhou Pharmaceutical Import and Export Co., Ltd
Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hong Kong company refers to Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hong Kong Company Limited
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) shares refer to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Pharmaceutical Co., Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Pharmaceutical General Factory refers to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Pharmaceutical General Factory
Chemical pharmaceutical factory refers to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) chemical pharmaceutical factory
He Jigong pharmaceutical factory refers to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) he Jigong pharmaceutical factory
Tianxin pharmaceutical refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Tianxin Pharmaceutical Co., Ltd
Guanghua pharmaceutical refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Guanghua Pharmaceutical Co., Ltd
Mingxing pharmaceutical refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Mingxing Pharmaceutical Co., Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hehuang company refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hutchison Huangpu traditional Chinese Medicine Co., Ltd
Huacheng pharmaceutical refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Huacheng Pharmaceutical Co., Ltd
Baiteqiaoguang refers to Guangzhou baiteqiaoguang medical supplies Co., Ltd
Nuocheng biology refers to Guangzhou nuocheng Biological Products Co., Ltd
Wanglaojiya’an company refers to wanglaojida health industry (Ya’an) Co., Ltd
Weiling pharmaceutical refers to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Weiling Pharmaceutical Co., Ltd
Xingzhu pharmaceutical refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Xingzhu Pharmaceutical Co., Ltd
Chemical Medicine Technology Co., Ltd. refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Chemical Medicine Technology Co., Ltd
Guangzhou Pharmaceutical General Hospital refers to Guangzhou Pharmaceutical Research Institute Co., Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) pharmaceutical sales company refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Pharmaceutical Sales Co., Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) medical and health industry company refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) medical and Health Industry Investment Co., Ltd
Medical device investment company refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) medical device investment Co., Ltd
Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) hospital refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) hospital Co., Ltd
Yigan biological refers to Guangzhou Guangyao Yigan Biological Products Co., Ltd
Haima company refers to Guangzhou Pharmaceutical Haima Brand Integrated Communication Co., Ltd
Zhuhai Hengqin Pharmaceutical Industrial Park Company refers to Guangyao (Zhuhai Hengqin) Pharmaceutical Industrial Park Co., Ltd
Chemical Pharmaceutical (Zhuhai) company refers to Guangyao Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Chemical Pharmaceutical (Zhuhai) Co., Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Yihu company refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Yihu Health Technology Co., Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) health care company refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) health care medical supplies Co., Ltd
Golden Eagle Fund refers to Golden Eagle Fund Management Co., Ltd
Runkangyue subsidiary refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) runkangyue Club Co., Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Yixintang Pharmaceutical Group Co.Ltd(002727) refers to Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Yixintang Pharmaceutical Group Co.Ltd(002727) pharmaceutical investment development Co., Ltd
C.Q.Pharmaceutical Holding Co.Ltd(000950) refers to C.Q.Pharmaceutical Holding Co.Ltd(000950)
The abbreviation of good manufacturing practice in English refers to a set of mandatory standards applicable to the pharmaceutical industry, which requires enterprises to ensure that the drug quality meets the national standards in accordance with the requirements of GMP in the process of drug production
The abbreviation of good agricultural practice, namely gap, refers to the production quality management specification of traditional Chinese medicine (for Trial Implementation).
It refers to
